Show simple item record

dc.creatorCaricchio, Roberto
dc.creatorGallucci, Marcello
dc.creatorDass, Chandra
dc.creatorZhang, Xinyan
dc.creatorGallucci, Stefania
dc.creatorFleece, David
dc.creatorBromberg, Michael
dc.creatorCriner, Gerard J.
dc.date.accessioned2020-11-11T21:00:55Z
dc.date.available2020-11-11T21:00:55Z
dc.date.issued2020-09-25
dc.identifier.citationCaricchio R, Gallucci M, Dass C Temple University COVID-19 Research Group, et al. Preliminary predictive criteria for COVID-19 cytokine storm. Annals of the Rheumatic Diseases Published Online First: 25 September 2020. doi: 10.1136/annrheumdis-2020-218323
dc.identifier.issn0003-4967
dc.identifier.doihttp://dx.doi.org/10.34944/dspace/4137
dc.identifier.urihttp://hdl.handle.net/20.500.12613/4155
dc.description.abstractObjectives: To develop predictive criteria for COVID-19-associated cytokine storm (CS), a severe hyperimmune response that results in organ damage in some patients infected with COVID-19. We hypothesised that criteria for inflammation and cell death would predict this type of CS. Methods: We analysed 513 hospitalised patients who were positive for COVID-19 reverse transcriptase PCR and for ground-glass opacity by chest high-resolution CT. To achieve an early diagnosis, we analysed the laboratory results of the first 7 days of hospitalisation. We implemented logistic regression and principal component analysis to determine the redictive criteria. We used a ’genetic algorithm’ to derive the cut-offs for each laboratory result. We validated the criteria with a second cohort of 258 patients. Results: We found that the criteria for macrophage activation syndrome, haemophagocytic lymphohistiocytosis and the HScore did not identify the COVID-19 cytokine storm (COVID-CS). We developed new predictive criteria, with sensitivity and specificity of 0.85 and 0.80, respectively, comprising three clusters of laboratory results that involve (1) inflammation, (2) cell death and tissue damage, and (3) prerenal electrolyte imbalance. The criteria identified patients with longer hospitalisation and increased mortality. These results highlight the relevance of hyperinflammation and tissue damage in the COVID-CS. Conclusions: We propose new early predictive criteria to identify the CS occurring in patients with COVID-19. The criteria can be readily used in clinical practice to determine the need for an early therapeutic regimen,block the hyperimmune response and possibly decrease mortality.
dc.format.extent8 pages
dc.languageEnglish
dc.language.isoeng
dc.relation.ispartofCOVID-19 Research
dc.relation.haspartAnnals of the Rheumatic Diseases
dc.relation.isreferencedbyBMJ
dc.rightsAttribution-NonCommercial CC BY-NC
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.titlePreliminary predictive criteria for COVID-19 cytokine storm
dc.typeText
dc.type.genrePost-print
dc.contributor.groupCOVID-19 Research Group (Temple University)
dc.description.departmentMedicine
dc.description.departmentRheumatology
dc.description.departmentRadiology
dc.description.departmentMicrobiology and Immunology
dc.description.departmentPediatrics
dc.description.departmentHematology
dc.description.departmentThoracic Medicine and Surgery
dc.relation.doihttp://doi.org/10.1136/annrheumdis-2020-218323
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.description.schoolcollegeLewis Katz School of Medicine
dc.creator.orcid0000-0002-1379-1118
dc.creator.orcid0000-0003-4737-8003
dc.temple.creatorCaricchio, Roberto
dc.temple.creatorGallucci, Marcello
dc.temple.creatorDass, Chandra
dc.temple.creatorZhang, Xinyan
dc.temple.creatorGallucci, Stefania
dc.temple.creatorFleece, David
dc.temple.creatorBromberg, Michael
dc.temple.creatorCriner, Gerard J.
refterms.dateFOA2020-11-11T21:00:55Z


Files in this item

Thumbnail
Name:
Caricchio-PostPrint-2020.pdf
Size:
442.5Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial CC BY-NC
Except where otherwise noted, this item's license is described as Attribution-NonCommercial CC BY-NC